melatonin has been researched along with Cholera Infantum in 22 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The serum melatonin levels were significantly higher in male patients with functional dyspepsia." | 7.81 | Melatonin may have a role in the pathogenesis of functional dyspepsia in males. ( Akyuz, F; Ciftci, S; Ermis, F; Keskin, F; Mungan, Z; Uyanikoglu, A; Yonal, O, 2015) |
| "Melatonin is a powerful antioxidant that resists oxidative stress due to its capacity to directly scavenge reactive species, to modulate the antioxidant defense system by increasing the activities of antioxidant enzymes, and to stimulate the innate immune response through its direct and indirect actions." | 6.55 | Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. ( Alatorre-Jiménez, MA; Antoñanzas-Lombarte, Á; Buisac-Ramón, C; Castán-Ruiz, S; Esteban-Zubero, E; García, JJ; López-Pingarrón, L; Ochoa-Moneo, P; Reiter, RJ; Rivas-Jiménez, M; Tan, DX, 2017) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "The serum melatonin levels were significantly higher in male patients with functional dyspepsia." | 3.81 | Melatonin may have a role in the pathogenesis of functional dyspepsia in males. ( Akyuz, F; Ciftci, S; Ermis, F; Keskin, F; Mungan, Z; Uyanikoglu, A; Yonal, O, 2015) |
| "Melatonin is a powerful antioxidant that resists oxidative stress due to its capacity to directly scavenge reactive species, to modulate the antioxidant defense system by increasing the activities of antioxidant enzymes, and to stimulate the innate immune response through its direct and indirect actions." | 2.55 | Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. ( Alatorre-Jiménez, MA; Antoñanzas-Lombarte, Á; Buisac-Ramón, C; Castán-Ruiz, S; Esteban-Zubero, E; García, JJ; López-Pingarrón, L; Ochoa-Moneo, P; Reiter, RJ; Rivas-Jiménez, M; Tan, DX, 2017) |
| "Melatonin is a hormone with endocrine, paracrine and autocrine actions." | 2.47 | Distribution, function and physiological role of melatonin in the lower gut. ( Bashashati, M; Chen, CQ; Fichna, J; Li, YY; Storr, M, 2011) |
| "Melatonin has been also used as a complementary treatment in anaesthesia, hemodialysis, in vitro fertilization and neonatal care." | 2.46 | Clinical uses of melatonin: evaluation of human trials. ( Mediavilla, MD; Reiter, RJ; Sánchez-Barceló, EJ; Tan, DX, 2010) |
| "Melatonin is a hormone with unique adaptive potential; its abnormal production and secretion rhythm trigger the mechanism of desynchronosis leading to organic pathology." | 2.45 | [Melatonin and its role in gastrointestinal pathology]. ( Rakhimova, OIu, 2009) |
| "Melatonin was also confirmed in the pancreas and the hepatobiliary system." | 2.44 | Thirty four years since the discovery of gastrointestinal melatonin. ( Bubenik, GA, 2008) |
| "Melatonin in GIT was shown to be generated in about 500 times larger amounts than it is produced in pineal gland." | 2.44 | Role of melatonin in upper gastrointestinal tract. ( Brzozowski, T; Bubenik, GA; Konturek, PC; Konturek, SJ, 2007) |
| "Melatonin was found also in large quantities in the embryonic tissue of the mammalian and avian gastrointestinal tract." | 2.41 | Gastrointestinal melatonin: localization, function, and clinical relevance. ( Bubenik, GA, 2002) |
| "Melatonin is a mammalian hormone that has a great variety of effects." | 1.35 | [Determination of melatonin receptors in human blood mononuclear cells: clinical and experimental rationale]. ( Gorchakova, MV; Rezvan, TA; Semenov, DIu; Shapkina, LG; Sokolov, AV; Stepnov, IA; Tonoian, AG; Vasil'ev, VB; Zyeva, EE, 2009) |
| "Treatment with omeprazole or melatonin prevented this damage as well as the changes in biochemical parameters, and melatonin appeared to be more efficient than omeprazole in protecting the mucosa." | 1.33 | Protective effect of melatonin and omeprazole against alendronat-induced gastric damage. ( Arbak, S; Dülger, GA; Ersoy, Y; Goren, FO; Sener, G; Ulusoy, NB, 2005) |
| "In patients with GERD and DUD melatonin concentration was lower than in healthy subjects - 27,2 +/- 8,5 pg/ml and 25,5 +/- 6,2 pg/ml respectively (p < 0,05; p < 0,01)." | 1.33 | Nocturnal secretion of melatonin in patients with upper digestive tract disorders. ( Błasiak, J; Chojnacki, C; Chojnacki, J; Harasiuk, A; Klupińska, G; Reiter, RJ; Stec-Michalska, K; Wiśniewska-Jarosińska, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Wang, F | 1 |
| Gao, Z | 1 |
| Huang, W | 1 |
| Zhang, X | 1 |
| Liu, F | 1 |
| Yi, H | 1 |
| Guan, J | 1 |
| Wu, X | 1 |
| Xu, H | 1 |
| Yin, S | 1 |
| Sánchez, AB | 1 |
| Clares, B | 1 |
| Rodríguez-Lagunas, MJ | 1 |
| Fábrega, MJ | 1 |
| Calpena, AC | 1 |
| Yang, LL | 1 |
| Stiernborg, M | 1 |
| Skott, E | 1 |
| Söderström, Å | 1 |
| Giacobini, M | 1 |
| Lavebratt, C | 1 |
| Boutrid, N | 1 |
| Rahmoune, H | 1 |
| Arushanian, ÉB | 2 |
| Ermis, F | 1 |
| Uyanikoglu, A | 1 |
| Akyuz, F | 1 |
| Yonal, O | 1 |
| Keskin, F | 1 |
| Ciftci, S | 1 |
| Mungan, Z | 1 |
| Esteban-Zubero, E | 1 |
| López-Pingarrón, L | 1 |
| Alatorre-Jiménez, MA | 1 |
| Ochoa-Moneo, P | 1 |
| Buisac-Ramón, C | 1 |
| Rivas-Jiménez, M | 1 |
| Castán-Ruiz, S | 1 |
| Antoñanzas-Lombarte, Á | 1 |
| Tan, DX | 2 |
| García, JJ | 1 |
| Reiter, RJ | 3 |
| Bubenik, GA | 4 |
| Semenov, DIu | 1 |
| Tonoian, AG | 1 |
| Stepnov, IA | 1 |
| Shapkina, LG | 1 |
| Vasil'ev, VB | 1 |
| Sokolov, AV | 1 |
| Zyeva, EE | 1 |
| Gorchakova, MV | 1 |
| Rezvan, TA | 1 |
| Rakhimova, OIu | 1 |
| Sánchez-Barceló, EJ | 1 |
| Mediavilla, MD | 1 |
| Kolesnikov, DB | 1 |
| Rapoport, SI | 1 |
| Voznesenskaia, LA | 1 |
| Chen, CQ | 1 |
| Fichna, J | 1 |
| Bashashati, M | 1 |
| Li, YY | 1 |
| Storr, M | 1 |
| de la Rocha, N | 1 |
| María, AO | 1 |
| Gianello, JC | 1 |
| Pelzer, L | 1 |
| Sener, G | 1 |
| Goren, FO | 1 |
| Ulusoy, NB | 1 |
| Ersoy, Y | 1 |
| Arbak, S | 1 |
| Dülger, GA | 1 |
| Klupińska, G | 1 |
| Wiśniewska-Jarosińska, M | 1 |
| Harasiuk, A | 1 |
| Chojnacki, C | 1 |
| Stec-Michalska, K | 1 |
| Błasiak, J | 1 |
| Chojnacki, J | 1 |
| Konturek, SJ | 2 |
| Konturek, PC | 2 |
| Brzozowska, I | 1 |
| Pawlik, M | 1 |
| Sliwowski, Z | 1 |
| Cześnikiewicz-Guzik, M | 1 |
| Kwiecień, S | 1 |
| Brzozowski, T | 2 |
| Pawlik, WW | 1 |
| Telakivi, T | 1 |
12 reviews available for melatonin and Cholera Infantum
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
[Melatonin as a drug: present status and perspectives].
Topics: Anti-Anxiety Agents; Antioxidants; Central Nervous System; Circadian Rhythm; Depression; Drug Admini | 2014 |
Melatonin's role as a co-adjuvant treatment in colonic diseases: A review.
Topics: Animals; Cell Proliferation; Colitis; Colitis, Ulcerative; Colonic Diseases; Enterocolitis, Necrotiz | 2017 |
Thirty four years since the discovery of gastrointestinal melatonin.
Topics: Animals; Antioxidants; Energy Intake; Gastrointestinal Diseases; Gastrointestinal Motility; Gastroin | 2008 |
[Melatonin and its role in gastrointestinal pathology].
Topics: Disease Progression; Gastrointestinal Diseases; Humans; Melatonin | 2009 |
Clinical uses of melatonin: evaluation of human trials.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Communicable Diseases; Endocrine System Diseases; | 2010 |
[Psychic disorders and gastrointestinal pathology. Part 2].
Topics: Gastrointestinal Diseases; Humans; Melatonin; Psychotic Disorders; Risk Factors | 2010 |
Distribution, function and physiological role of melatonin in the lower gut.
Topics: Animals; Clinical Trials as Topic; Colon; Gastrointestinal Diseases; Gastrointestinal Motility; Gast | 2011 |
[Pineal hormone melatonin in complex pharmacotherapy of brain and somatic disorders].
Topics: Animals; Brain Diseases; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Gastroi | 2011 |
Gastrointestinal melatonin: localization, function, and clinical relevance.
Topics: Animals; Digestive System; Gastrointestinal Diseases; Humans; Melatonin; Muscle Tonus; Pineal Gland; | 2002 |
Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
Topics: Animals; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Melatonin; Models, Biological; M | 2007 |
Role of melatonin in upper gastrointestinal tract.
Topics: Acetylserotonin O-Methyltransferase; Animals; Antioxidants; Arylalkylamine N-Acetyltransferase; Eati | 2007 |
1 trial available for melatonin and Cholera Infantum
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
10 other studies available for melatonin and Cholera Infantum
| Article | Year |
|---|---|
Melatonin attenuates chronic intermittent hypoxia-induced intestinal barrier dysfunction in mice.
Topics: Animals; Caco-2 Cells; Cytokines; Dysbiosis; Gastrointestinal Diseases; Humans; Hypoxia; Melatonin; | 2023 |
Study of Melatonin as Preventive Agent of Gastrointestinal Damage Induced by Sodium Diclofenac.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Diclofenac | 2020 |
Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Attention Deficit Disorder with Hyperactivity; Autistic Di | 2020 |
"3M": Migraine, Microbiota and Melatonin.
Topics: Gastrointestinal Diseases; Gastrointestinal Microbiome; Humans; Melatonin; Migraine Disorders | 2019 |
Melatonin may have a role in the pathogenesis of functional dyspepsia in males.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Female; | 2015 |
[Determination of melatonin receptors in human blood mononuclear cells: clinical and experimental rationale].
Topics: Adult; Aged; Antibodies; Erythrocytes; Fluorescent Antibody Technique, Indirect; Gastrointestinal Di | 2009 |
Cytoprotective effects of chalcones from Zuccagnia punctata and melatonin on the gastroduodenal tract in rats.
Topics: Analysis of Variance; Animals; Antioxidants; Chalcone; Chalcones; Ethanol; Fabaceae; Gastrointestina | 2003 |
Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.
Topics: Administration, Oral; Alendronate; Animals; Anti-Ulcer Agents; Antioxidants; Fasting; Female; Gastri | 2005 |
Nocturnal secretion of melatonin in patients with upper digestive tract disorders.
Topics: Adult; Circadian Rhythm; Duodenal Ulcer; Dyspepsia; Female; Gastroesophageal Reflux; Gastrointestina | 2006 |
[Melatonin and time zone transition].
Topics: Circadian Rhythm; Gastrointestinal Diseases; Humans; Melatonin; Pituitary Gland; Sensitivity and Spe | 1996 |